Cargando…

IgG4-related aortitis/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease

BACKGROUND: Large vessels could be involved in immunoglobulin (Ig)-G4-related disease (IgG4-RD). This study aimed to clarify the clinical features and evaluate the treatment efficacy for IgG4-RD with aortitis/periaortitis and periarteritis (PAO/PA). METHODS: This study prospectively enrolled 587 pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Linyi, Zhang, Panpan, Li, Jieqiong, Liu, Zheng, Lu, Hui, Zhu, Liang, Wang, Xiaorong, Teng, Fei, Li, Xuemei, Guo, Huifang, Fei, Yunyun, Zhang, Wen, Zhao, Yan, Zeng, Xiaofeng, Zhang, Fengchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197178/
https://www.ncbi.nlm.nih.gov/pubmed/32366271
http://dx.doi.org/10.1186/s13075-020-02197-w
_version_ 1783528830680432640
author Peng, Linyi
Zhang, Panpan
Li, Jieqiong
Liu, Zheng
Lu, Hui
Zhu, Liang
Wang, Xiaorong
Teng, Fei
Li, Xuemei
Guo, Huifang
Fei, Yunyun
Zhang, Wen
Zhao, Yan
Zeng, Xiaofeng
Zhang, Fengchun
author_facet Peng, Linyi
Zhang, Panpan
Li, Jieqiong
Liu, Zheng
Lu, Hui
Zhu, Liang
Wang, Xiaorong
Teng, Fei
Li, Xuemei
Guo, Huifang
Fei, Yunyun
Zhang, Wen
Zhao, Yan
Zeng, Xiaofeng
Zhang, Fengchun
author_sort Peng, Linyi
collection PubMed
description BACKGROUND: Large vessels could be involved in immunoglobulin (Ig)-G4-related disease (IgG4-RD). This study aimed to clarify the clinical features and evaluate the treatment efficacy for IgG4-RD with aortitis/periaortitis and periarteritis (PAO/PA). METHODS: This study prospectively enrolled 587 patients with IgG4-RD with a follow-up time of more than 6 months. The distribution of IgG4-related PAO/PA was classified into four types: type 1, thoracic aorta; type 2a, abdominal aorta; type 2b, abdominal aorta and iliac artery; type 2c, iliac artery; type 3, thoracic and abdominal aorta; and type 4, other arteries. Patient’s demographic data, clinical characteristics, laboratory parameters, and treatment efficacy were analyzed. RESULTS: Of 587 IgG4-RD patients, 89 (15.2%) had PAO/PA. The average age was 58.3 ± 11.1 years, with male predominance (85.4%). Vessels affected were as follows: abdominal aorta (83.1%), iliac artery (70.8%), thoracic aorta (13.5%), and other vessels (13.5%). The most prevalent distribution type of IgG4-related PAO/PA was type 2b, with 74 (83.1%) patients, followed by type 2a, type 2c, type 3, and type 1. Fifty-five (61.8%) PAO/PA patients had hydronephrosis, with renal insufficiency occurring in 43 (48.3%), and 31 (34.8%) PAO/PA patients had D-J stent drainage due to severe ureteral obstruction. After treatment with a glucocorticoid and immunosuppressants, 82% patients achieved remission with shrinking of the perivascular mass by more than 30%. CONCLUSIONS: IgG4-RD with PAO/PA was distinct from non-PAO/PA in demographic features, organ involvement distribution, inflammatory markers, and serum IgG4 and IgE. The most common affected vessel was the abdominal aorta, and most patients responded well with treatment.
format Online
Article
Text
id pubmed-7197178
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-71971782020-05-08 IgG4-related aortitis/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease Peng, Linyi Zhang, Panpan Li, Jieqiong Liu, Zheng Lu, Hui Zhu, Liang Wang, Xiaorong Teng, Fei Li, Xuemei Guo, Huifang Fei, Yunyun Zhang, Wen Zhao, Yan Zeng, Xiaofeng Zhang, Fengchun Arthritis Res Ther Research Article BACKGROUND: Large vessels could be involved in immunoglobulin (Ig)-G4-related disease (IgG4-RD). This study aimed to clarify the clinical features and evaluate the treatment efficacy for IgG4-RD with aortitis/periaortitis and periarteritis (PAO/PA). METHODS: This study prospectively enrolled 587 patients with IgG4-RD with a follow-up time of more than 6 months. The distribution of IgG4-related PAO/PA was classified into four types: type 1, thoracic aorta; type 2a, abdominal aorta; type 2b, abdominal aorta and iliac artery; type 2c, iliac artery; type 3, thoracic and abdominal aorta; and type 4, other arteries. Patient’s demographic data, clinical characteristics, laboratory parameters, and treatment efficacy were analyzed. RESULTS: Of 587 IgG4-RD patients, 89 (15.2%) had PAO/PA. The average age was 58.3 ± 11.1 years, with male predominance (85.4%). Vessels affected were as follows: abdominal aorta (83.1%), iliac artery (70.8%), thoracic aorta (13.5%), and other vessels (13.5%). The most prevalent distribution type of IgG4-related PAO/PA was type 2b, with 74 (83.1%) patients, followed by type 2a, type 2c, type 3, and type 1. Fifty-five (61.8%) PAO/PA patients had hydronephrosis, with renal insufficiency occurring in 43 (48.3%), and 31 (34.8%) PAO/PA patients had D-J stent drainage due to severe ureteral obstruction. After treatment with a glucocorticoid and immunosuppressants, 82% patients achieved remission with shrinking of the perivascular mass by more than 30%. CONCLUSIONS: IgG4-RD with PAO/PA was distinct from non-PAO/PA in demographic features, organ involvement distribution, inflammatory markers, and serum IgG4 and IgE. The most common affected vessel was the abdominal aorta, and most patients responded well with treatment. BioMed Central 2020-05-04 2020 /pmc/articles/PMC7197178/ /pubmed/32366271 http://dx.doi.org/10.1186/s13075-020-02197-w Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Peng, Linyi
Zhang, Panpan
Li, Jieqiong
Liu, Zheng
Lu, Hui
Zhu, Liang
Wang, Xiaorong
Teng, Fei
Li, Xuemei
Guo, Huifang
Fei, Yunyun
Zhang, Wen
Zhao, Yan
Zeng, Xiaofeng
Zhang, Fengchun
IgG4-related aortitis/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease
title IgG4-related aortitis/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease
title_full IgG4-related aortitis/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease
title_fullStr IgG4-related aortitis/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease
title_full_unstemmed IgG4-related aortitis/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease
title_short IgG4-related aortitis/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease
title_sort igg4-related aortitis/periaortitis and periarteritis: a distinct spectrum of igg4-related disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197178/
https://www.ncbi.nlm.nih.gov/pubmed/32366271
http://dx.doi.org/10.1186/s13075-020-02197-w
work_keys_str_mv AT penglinyi igg4relatedaortitisperiaortitisandperiarteritisadistinctspectrumofigg4relateddisease
AT zhangpanpan igg4relatedaortitisperiaortitisandperiarteritisadistinctspectrumofigg4relateddisease
AT lijieqiong igg4relatedaortitisperiaortitisandperiarteritisadistinctspectrumofigg4relateddisease
AT liuzheng igg4relatedaortitisperiaortitisandperiarteritisadistinctspectrumofigg4relateddisease
AT luhui igg4relatedaortitisperiaortitisandperiarteritisadistinctspectrumofigg4relateddisease
AT zhuliang igg4relatedaortitisperiaortitisandperiarteritisadistinctspectrumofigg4relateddisease
AT wangxiaorong igg4relatedaortitisperiaortitisandperiarteritisadistinctspectrumofigg4relateddisease
AT tengfei igg4relatedaortitisperiaortitisandperiarteritisadistinctspectrumofigg4relateddisease
AT lixuemei igg4relatedaortitisperiaortitisandperiarteritisadistinctspectrumofigg4relateddisease
AT guohuifang igg4relatedaortitisperiaortitisandperiarteritisadistinctspectrumofigg4relateddisease
AT feiyunyun igg4relatedaortitisperiaortitisandperiarteritisadistinctspectrumofigg4relateddisease
AT zhangwen igg4relatedaortitisperiaortitisandperiarteritisadistinctspectrumofigg4relateddisease
AT zhaoyan igg4relatedaortitisperiaortitisandperiarteritisadistinctspectrumofigg4relateddisease
AT zengxiaofeng igg4relatedaortitisperiaortitisandperiarteritisadistinctspectrumofigg4relateddisease
AT zhangfengchun igg4relatedaortitisperiaortitisandperiarteritisadistinctspectrumofigg4relateddisease